Financial Ratios

DECCAN HEALTH CARE LTD.

NSE : NABSE : 542248ISIN CODE : INE452W01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE27.62-0.47 (-1.67 %)
PREV CLOSE ( ) 28.09
OPEN PRICE ( ) 28.67
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 81949
TODAY'S LOW / HIGH ( )27.29 29.00
52 WK LOW / HIGH ( ) 23.142
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.270.210.256.429.22
   CEPS(Rs)1.101.141.187.3210.03
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)47.9148.9748.7648.5142.09
   Tax Rate(%)25.1640.4224.890.440.59
Margin Ratios
   Core EBITDA Margin(%)4.7316.126.0327.6437.98
   EBIT Margin(%)1.592.101.8624.4235.26
   Pre Tax Margin(%)1.351.641.5423.9832.92
   PAT Margin (%)1.010.981.1523.8832.73
   Cash Profit Margin (%)4.185.425.4927.2335.63
Performance Ratios
   ROA(%)0.490.350.4211.4718.89
   ROE(%)0.570.420.5114.1725.78
   ROCE(%)0.890.890.8114.2225.04
   Asset Turnover(x)0.480.360.360.480.58
   Sales/Fixed Asset(x)1.350.991.011.301.50
   Working Capital/Sales(x)0.710.580.630.811.02
Efficiency Ratios
   Fixed Capital/Sales(x)0.741.010.990.770.67
   Receivable days100.83139.13178.45172.54152.82
   Inventory Days378.03503.32447.82302.39213.26
   Payable days103.56144.97125.92160.93161.48
Valuation Parameters
   PER(x)102.88173.29118.494.2811.62
   PCE(x)24.8931.2624.893.7510.67
   Price/Book(x)0.570.730.600.572.54
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.021.651.300.973.73
   EV/Core EBITDA(x)21.489.8421.033.499.78
   EV/EBIT(x)64.2078.7170.203.9710.58
   EV/CE(x)0.480.600.480.441.99
   M Cap / Sales1.041.691.371.023.80
Growth Ratio
   Net Sales Growth(%)35.72-1.79-20.05-4.5316.97
   Core EBITDA Growth(%)-61.47166.05-82.16-30.534.75
   EBIT Growth(%)3.1910.97-93.92-33.895.12
   PAT Growth(%)40.57-16.88-96.13-30.348.39
   EPS Growth(%)29.57-16.86-96.13-30.34-6.87
Financial Stability Ratios
   Total Debt/Equity(x)0.010.020.010.020.02
   Current Ratio(x)6.116.485.234.844.20
   Quick Ratio(x)2.332.041.692.061.84
   Interest Cover(x)6.584.585.8156.3015.06
   Total Debt/Mcap(x)0.010.020.020.030.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.